GFACX
Price
$72.97
Change
-$0.51 (-0.69%)
Updated
Nov 18 closing price
Net Assets
329.73B
USLCX
Price
$42.77
Change
-$0.43 (-1.00%)
Updated
Nov 18 closing price
Net Assets
1.75B
Interact to see
Advertisement

GFACX vs USLCX

Header iconGFACX vs USLCX Comparison
Open Charts GFACX vs USLCXBanner chart's image
American Funds Growth Fund of Amer C
Price$72.97
Change-$0.51 (-0.69%)
VolumeN/A
Net Assets329.73B
JHancock U.S. Global Leaders Growth C
Price$42.77
Change-$0.43 (-1.00%)
VolumeN/A
Net Assets1.75B
GFACX vs USLCX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. USLCX commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and USLCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 330B vs. USLCX (1.75B). GFACX (0.00) and USLCX (0.00) have matching dividends . GFACX was incepted earlier than USLCX: GFACX (25 years) vs USLCX (24 years). USLCX (1.89) is less costly to investors than GFACX (1.36). USLCX is a more actively managed with annual turnover of: 29.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than USLCX: GFACX (250) vs USLCX (1000). GFACX annual gain was more profitable for investors over the last year : 5.07 vs. USLCX (-20.76). GFACX return over 5 years is better than : 24.08 vs. USLCX (-19.78).
GFACXUSLCXGFACX / USLCX
Total Expense Ratio1.361.8872%
Annual Report Gross Expense Ratio1.361.8972%
Fund Existence25 years24 years-
Gain YTD14.445-1.639-881%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets330B1.75B18,846%
Annual Yield % from dividends0.000.00-
Returns for 1 year5.07-20.76-24%
Returns for 3 years54.8618.10303%
Returns for 5 years24.08-19.78-122%
Returns for 10 years69.6610.15686%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FBIOP6.900.21
+3.13%
Fortress Biotech
TLPH1.340.02
+1.52%
Talphera
JANX29.020.30
+1.04%
Janux Therapeutics
MBAV10.580.01
+0.09%
M3 Brigade Acquisition V Corp.
CDE14.38-0.08
-0.55%
Coeur Mining